Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors
nect Biopharma (US:CNTB) Globenewswireยท2025-07-22 13:00"I am delighted to join Connect and have been impressed by the potential of rademikibart to transform the treatment paradigm for acute and chronic asthma and COPD patients. I look forward to working closely with the team to guide the Company's development efforts and chart a course for long-term commercial success," said Mr. Schoeneck. Mr. Schoeneck is an accomplished biotech leader with more than 40 years of experience developing and commercializing breakthrough medicines and guiding companies through sign ...